Mounjaro

Mounjaro® (tirzepatide) is a once-weekly injectable medication that works on GIP and GLP-1 hormone pathways to help regulate appetite, food intake, and blood sugar. When used as part of a personalized treatment plan that includes healthy nutrition and physical activity, tirzepatide can support meaningful weight reduction. Your healthcare provider can evaluate your health, weight-management goals, medications, and medical history to determine whether tirzepatide-based treatment is appropriate for you. Mounjaro is FDA-approved for improving blood sugar control in people with type 2 diabetes, while tirzepatide is also FDA-approved for chronic weight management under the brand name Zepbound.

Frequently Asked Questions

How does Mounjaro help with weight loss?

Mounjaro contains tirzepatide, which activates GIP and GLP-1 receptors involved in appetite regulation and glucose metabolism. These effects can help reduce appetite and food intake, making it easier for some patients to follow a reduced-calorie eating plan.

Weight loss results can vary from person to person and depend on factors such as dosage, diet, physical activity, medical conditions, and treatment duration. Your healthcare provider can monitor your progress and adjust your treatment plan when appropriate.

How often is tirzepatide taken for weight management?

Tirzepatide is administered as a subcutaneous injection once weekly. The dose is generally started at a lower level and may be gradually increased based on the patient’s response and tolerability under medical supervision.

Patients should follow their prescribed dosing schedule and should not change the dose or combine tirzepatide with other GLP-1 medications without guidance from their healthcare provider.

What side effects can occur with tirzepatide?

The most common side effects associated with Mounjaro include nausea, diarrhea, decreased appetite, vomiting, constipation, indigestion, and abdominal discomfort or pain. These effects may be more noticeable when treatment is started or the dose is increased.

Tirzepatide also has important warnings and precautions, including risks involving the thyroid, pancreas, gallbladder, kidneys, and gastrointestinal system. It should not be used by people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. Discuss your complete medical history with your healthcare provider before treatment.

Is Mounjaro right for everyone who wants to lose weight?

No. Weight-management medications are not appropriate for everyone. A healthcare professional should review your medical history, current medications, weight-related health conditions, and treatment goals before recommending tirzepatide.

For chronic weight management, FDA-approved tirzepatide under the brand name Zepbound is indicated for certain adults with obesity or overweight with at least one weight-related health condition, alongside a reduced-calorie diet and increased physical activity.